Recurrent Ovarian Germ Cell Tumor Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408655Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsTreatment